Literature DB >> 8636243

Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2.

R H Schwall1, L Y Chang, P J Godowski, D W Kahn, K J Hillan, K D Bauer, T F Zioncheck.   

Abstract

Hepatocyte growth factor (HGF) is a potent epithelial mitogen whose actions are mediated through its receptor, the proto-oncogene c-Met. Two truncated variants of HGF known as NK1 and NK2 have been reported to be competitive inhibitors of HGF binding to c-Met, and to function as HGF antagonists (Lokker, N.A., and P.J. Godowski. 1993. J. Biol. Chem. 268: 17145-17150; Chan, A.M., J.S. Rubin, D.P. Bottaro, D.W. Hirschfield, M. Chedid, and S.A. Aaronson. 1991. Science (Wash. DC). 254:1382-1387). We show here, however, that NK1 acts as a partial agonist in mink lung cells. Interestingly, NK1, which is an HGF antagonist in hepatocytes in normal conditions, was converted to a partial agonist by adding heparin to the culture medium. The interaction of NK1 and heparin was further studied in BaF3 cells, which express little or no cell surface heparan sulfate proteoglycans. In BaF3 cells transfected with a plasmid encoding human c-Met, heparin and NK1 synergized to stimulate DNA synthesis and cell proliferation. There was no effect of heparin on the IL-3 sensitivity of BaF3-hMet cells, and no effect of NK1 plus heparin in control BaF3 cells, indicating that the response was specific and mediated through c-Met. The naturally occurring HGF splice variant NK2 also stimulated DNA synthesis in mink lung cells and exerted a heparin-dependent effect on BaF3-hMet cells, but not on BaF3-neo cells. The activating effect of heparin was mimicked by a variety of sulfated glycosaminoglycans. Mechanistic studies revealed that heparin increased the binding of NK1 to BaF3-hMet cells, stabilized NK1, and induced dimerization of NK1. Based on these studies, we propose that the normal agonist activity of NK1 and NK2 in mink lung cells is due to an activating interaction with an endogenous glycosaminoglycan. Consistent with that model, a large portion of the NK1 binding to mink lung cells could be blocked by heparin. Moreover, a preparation of glycosaminoglycans from the surface of mink lung cells induced dimerization of NK1. These data show that the activity of NK1 and NK2 can be modulated by heparin and other related glycosaminoglycans to induce proliferation in cells expressing c-Met.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8636243      PMCID: PMC2120823          DOI: 10.1083/jcb.133.3.709

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  41 in total

Review 1.  Glycosaminoglycans: molecular properties, protein interactions, and role in physiological processes.

Authors:  R L Jackson; S J Busch; A D Cardin
Journal:  Physiol Rev       Date:  1991-04       Impact factor: 37.312

Review 2.  Proteoglycans as modulators of growth factor activities.

Authors:  E Ruoslahti; Y Yamaguchi
Journal:  Cell       Date:  1991-03-08       Impact factor: 41.582

3.  The hormonal control of gluconeogenesis by regulation of mitochondrial pyruvate carboxylation in isolated rat liver cells.

Authors:  J C Garrison; R C Haynes
Journal:  J Biol Chem       Date:  1975-04-25       Impact factor: 5.157

4.  Identity of a tumor cytotoxic factor from human fibroblasts and hepatocyte growth factor.

Authors:  K Higashio; N Shima; M Goto; Y Itagaki; M Nagao; H Yasuda; T Morinaga
Journal:  Biochem Biophys Res Commun       Date:  1990-07-16       Impact factor: 3.575

5.  Biosynthesis of the protein encoded by the c-met proto-oncogene.

Authors:  S Giordano; M F Di Renzo; R P Narsimhan; C S Cooper; C Rosa; P M Comoglio
Journal:  Oncogene       Date:  1989-11       Impact factor: 9.867

6.  Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor.

Authors:  A Yayon; M Klagsbrun; J D Esko; P Leder; D M Ornitz
Journal:  Cell       Date:  1991-02-22       Impact factor: 41.582

7.  Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

Authors:  D P Bottaro; J S Rubin; D L Faletto; A M Chan; T E Kmiecik; G F Vande Woude; S A Aaronson
Journal:  Science       Date:  1991-02-15       Impact factor: 47.728

8.  An alternatively processed mRNA generated from human hepatocyte growth factor gene.

Authors:  K Miyazawa; A Kitamura; D Naka; N Kitamura
Journal:  Eur J Biochem       Date:  1991-04-10

9.  Overexpression of the c-MET/HGF receptor in human thyroid carcinomas derived from the follicular epithelium.

Authors:  M F Di Renzo; M Olivero; G Serini; F Orlandi; S Pilotti; A Belfiore; A Costantino; R Vigneri; A Angeli; M A Pierotti
Journal:  J Endocrinol Invest       Date:  1995-02       Impact factor: 4.256

10.  Scatter factor: molecular characteristics and effect on the invasiveness of epithelial cells.

Authors:  K M Weidner; J Behrens; J Vandekerckhove; W Birchmeier
Journal:  J Cell Biol       Date:  1990-11       Impact factor: 10.539

View more
  31 in total

1.  Proteomic analysis of heparin-binding proteins from human seminal plasma: a step towards identification of molecular markers of male fertility.

Authors:  Vijay Kumar; Md Imtaiyaz Hassan; Anil Kumar Tomar; Tara Kashav; Jaya Nautiyal; Sarman Singh; Tej P Singh; Savita Yadav
Journal:  J Biosci       Date:  2009-12       Impact factor: 1.826

2.  An engineered dimeric fragment of hepatocyte growth factor is a potent c-MET agonist.

Authors:  Cassie J Liu; Douglas S Jones; Ping-Chuan Tsai; Abhishek Venkataramana; Jennifer R Cochran
Journal:  FEBS Lett       Date:  2014-11-21       Impact factor: 4.124

3.  Functional and biophysical characterization of recombinant human hepatocyte growth factor isoforms produced in Escherichia coli.

Authors:  S J Stahl; P T Wingfield; J D Kaufman; L K Pannell; V Cioce; H Sakata; W G Taylor; J S Rubin; D P Bottaro
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  Disassociation of met-mediated biological responses in vivo: the natural hepatocyte growth factor/scatter factor splice variant NK2 antagonizes growth but facilitates metastasis.

Authors:  T Otsuka; J Jakubczak; W Vieira; D P Bottaro; D Breckenridge; W J Larochelle; G Merlino
Journal:  Mol Cell Biol       Date:  2000-03       Impact factor: 4.272

5.  Neutralizing monoclonal antibodies to hepatocyte growth factor/scatter factor (HGF/SF) display antitumor activity in animal models.

Authors:  B Cao; Y Su; M Oskarsson; P Zhao; E J Kort; R J Fisher; L M Wang; G F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2001-06-19       Impact factor: 11.205

6.  NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo.

Authors:  J L Jakubczak; W J LaRochelle; G Merlino
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

7.  Crystal structures of NK1-heparin complexes reveal the basis for NK1 activity and enable engineering of potent agonists of the MET receptor.

Authors:  D Lietha; D Y Chirgadze; B Mulloy; T L Blundell; E Gherardi
Journal:  EMBO J       Date:  2001-10-15       Impact factor: 11.598

8.  Prenatal expression of MET receptor tyrosine kinase in the fetal mouse dorsal raphe nuclei and the visceral motor/sensory brainstem.

Authors:  Hsiao-Huei Wu; Pat Levitt
Journal:  Dev Neurosci       Date:  2013-03-20       Impact factor: 2.984

9.  Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent.

Authors:  Mark Merchant; Xiaolei Ma; Henry R Maun; Zhong Zheng; Jing Peng; Mally Romero; Arthur Huang; Nai-ying Yang; Merry Nishimura; Joan Greve; Lydia Santell; Yu-Wen Zhang; Yanli Su; Dafna W Kaufman; Karen L Billeci; Elaine Mai; Barbara Moffat; Amy Lim; Eileen T Duenas; Heidi S Phillips; Hong Xiang; Judy C Young; George F Vande Woude; Mark S Dennis; Dorothea E Reilly; Ralph H Schwall; Melissa A Starovasnik; Robert A Lazarus; Daniel G Yansura
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-23       Impact factor: 11.205

10.  High concentrations of HGF inhibit skeletal muscle satellite cell proliferation in vitro by inducing expression of myostatin: a possible mechanism for reestablishing satellite cell quiescence in vivo.

Authors:  Michiko Yamada; Ryuichi Tatsumi; Keitaro Yamanouchi; Tohru Hosoyama; Sei-ichi Shiratsuchi; Akiko Sato; Wataru Mizunoya; Yoshihide Ikeuchi; Mitsuhiro Furuse; Ronald E Allen
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-09       Impact factor: 4.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.